首页|血脂亚组与动脉粥样硬化性心血管疾病的研究进展

血脂亚组与动脉粥样硬化性心血管疾病的研究进展

扫码查看
动脉粥样硬化性心血管疾病(ASCVD)具有高发病率和高致死率的特征,是加重全球疾病负担的主要原因.血脂异常,特别是低密度脂蛋白胆固醇(LDL-C)异常,是ASCVD的主要危险因素之一.研究发现LDL-C正常人群仍存在 ASCVD 风险,此外,研究表明血脂亚组在预测ASCVD风险方面比 LDL-C 更准确.自血脂亚组被发现以来,研究人员一直在寻找高致动脉粥样硬化特性的血脂亚组,从而为ASCVD提供新的生物标志物和治疗靶点.因此,文章就血脂亚组的性质、检测方法及其与ASCVD的相关性作一综述,为血脂亚组的临床预测价值提供理论基础.
Lipid Subgroups and Atherosclerotic Cardiovascular Disease:a Review
Atherosclerotic cardiovascular disease(ASCVD),characterised by high morbidity and lethality,is a major contributor to the global disease burden.Dyslipidemia,especially low-density lipoprotein cholesterol(LDL-C)abnormality,is one of the major risk factors for ASCVD.It has been found that ASCVD risk still exists in populations with normal LDL-C,and furthermore,it has been shown that lipid subgroups are more accurate than LDL-C in predicting ASCVD risk.Since the discovery of lipid subgroups,researchers have been searching for lipoprotein subfractions with high atherogenic properties that could provide new biomarkers and therapeutic targets for ASCVD.This article provides a review of the nature of lipid subgroups,detection methods,and the correlation with ASCVD,in order to provide a theoretical basis for the clinical predictive value of lipid subgroups.

lipid subgroupatherosclerotic cardiovascular diseasedyslipidemialipoprotein

郝博宇、熊晶

展开 >

南昌大学第一附属医院全科医疗科,南昌 330006

血脂亚组 动脉粥样硬化性心血管疾病 血脂异常 脂蛋白

2024

实用临床医学
南昌大学

实用临床医学

影响因子:0.818
ISSN:1009-8194
年,卷(期):2024.25(5)
  • 9